Last reviewed · How we verify
no added fluoride in a silica base
This drug works by providing a silica base without added fluoride.
This drug works by providing a silica base without added fluoride. Used for Dental caries prevention.
At a glance
| Generic name | no added fluoride in a silica base |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
The silica base is used as a carrier for the drug, providing a stable and consistent delivery system. The lack of added fluoride is intended to reduce the risk of dental fluorosis and other potential side effects associated with fluoride exposure.
Approved indications
- Dental caries prevention
Common side effects
- Gastrointestinal upset
- Dental fluorosis (due to potential cross-contamination)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- no added fluoride in a silica base CI brief — competitive landscape report
- no added fluoride in a silica base updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI